Blueberry Visual Performance Randomized Trial: What the Evidence Says

Quick Answer

Blueberry Visual Performance Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Slower gastric emptying contributes to improved satiety and a more gradual glucose response following meals. [Ellis Lucy R. (2026); evidence level 2]
• By improving satiety response to a meal, this may reduce the risk of obesity and other metabolic conditions such as type 2 diabetes mellitus or metabolic syndrome. [Ellis Lucy R. (2026); evidence level 2]
• Among these, the amnestic subtype, characterized predominantly by memory impairment, is particularly associated with an increased risk of progression to Alzheimer's disease dementia (AD). [dos Santos Gustavo Alves Andrade (2026); evidence level 3]
• The risk of progression is significantly higher in individuals diagnosed with MCI than in age-matched cognitively unimpaired populations. [dos Santos Gustavo Alves Andrade (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For blueberry visual performance randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Ellis Lucy R. (2026). A randomised, double-blind, placebo-controlled trial to assess the postprandial dose-dependent effects of wild blueberries on metabolic and cognitive outcomes following a high-carbohydrate breakfast. DOI: 10.1007/s00394-026-03974-0. PMCID: PMC13212708. PMID: 42191861. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13212708/
• dos Santos Gustavo Alves Andrade (2026). Berry Consumption and Its Role in the Modulation of Obesity and Mild Cognitive Impairment. DOI: 10.3390/nu18040674. PMCID: PMC12943443. PMID: 41754191. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12943443/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.